Intervention for Peripheral Arterial Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Northwestern University, Chicago, IL
Peripheral Arterial Disease+1 More
PAD education video - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This study will test whether, among patients undergoing surgery for peripheral artery disease (PAD), the addition of an online multimedia patient education video to the current education regimen will improve PAD knowledge, activation, and self-care engagement. The study will randomize 150 participants to one of 2 groups: current education regimen vs. current education regiment with video. The primary outcome is stage of self-care engagement. Secondary outcomes are PAD knowledge, self-efficacy, and activation. A subset of participants will also be randomly selected to participate in semi-structured interviews. Study duration for participants is 6 months.

Eligible Conditions

  • Peripheral Arterial Disease
  • Peripheral Arterial Disease (PAD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Peripheral Arterial Disease

1
2

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline to six-month follow-up

Baseline to six-month follow-up
Activation level
PAD knowledge and beliefs
Readiness to change self-care engagement
Self-efficacy

Trial Safety

Safety Progress

1 of 3

Other trials for Peripheral Arterial Disease

1
2

Trial Design

2 Treatment Groups

Current education regimen
1 of 2
Intervention
1 of 2
Active Control

150 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Current education regimenNoIntervention Group · 1 Intervention: Current education regimen · Intervention Types:
Intervention
Other
ActiveComparator Group · 1 Intervention: PAD education video · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to six-month follow-up

Trial Background

Prof. Karen Ho, Assistant Professor
Principal Investigator
Northwestern University
Closest Location: Northwestern University · Chicago, IL
Photo of Northwestern University  1Photo of Northwestern University  2Photo of Northwestern University  3
1993First Recorded Clinical Trial
17 TrialsResearching Peripheral Arterial Disease
1040 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.